Company Information
CIN
Status
Date of Incorporation
04 October 1989
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2023
Paid Up Capital
31,040,000
Authorised Capital
50,000,000
Directors
Jayshree Sameer Chandurkar
Director/Designated Partner
over 2 years ago
over 2 years ago
Sameer Madhukar Chandurkar
Director/Designated Partner
over 2 years ago
over 2 years ago
Manish Girishbhai Shah
Director/Designated Partner
about 4 years ago
about 4 years ago
Madhukar Ramchandra Chandurkar
Beneficial Owner
almost 6 years ago
almost 6 years ago
Past Directors
Vijay Dinkar Tikekar
Director
about 21 years ago
about 21 years ago
Rose Robert Dmello
Director
over 27 years ago
over 27 years ago
Registered Trademarks
[Class : 5] Medicinal And Pharmaceutical Preparations And Substances.
[Class : 10] Diagnostic Apparatus And Instruments For Medical Use; Testing Apparatus And Instruments For Medical Purposes
[Class : 5] Medicinal And Pharmaceutical Preparations And Substances.
View +155 more Brands for Edge Pharma Private Limited.
Documents
Form BEN - 2-21122019_signed
Declaration under section 90-21122019
Form MGT-7-15122019_signed
Form AOC - 4 CFS-13122019_signed
List of share holders, debenture holders;-29112019
Supplementary or Test audit report under section 143-28112019
Consolidated Financial statements duly authenticated as per section 134 (Including Boards report, auditors report and other docu-28112019
Form AOC-4-28112019_signed
Details of salient features and justifications for entering into Contracts/Arrangements/Transactions with related parties as per section 188 (1) - Form AOC - 2-27112019
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-27112019
Optional Attachment-(1)-27112019
Directors report as per section 134(3)-27112019
Form DPT-3-16102019-signed
Form AOC - 4 CFS-27062019_signed
Supplementary or Test audit report under section 143-26062019
Consolidated Financial statements duly authenticated as per section 134 (Including Boards report, auditors report and other docu-26062019
Form AOC - 4 CFS-19062019-signed
Supplementary or Test audit report under section 143-18062019
Consolidated Financial statements duly authenticated as per section 134 (Including Boards report, auditors report and other docu-18062019
Supplementary or Test audit report under section 143-09052019
Consolidated Financial statements duly authenticated as per section 134 (Including Boards report, auditors report and other docu-09052019
Form AOC-4-09052019-signed
Form AOC-4-08042019_signed
Form MGT-7-08042019_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-05042019
Details of salient features and justifications for entering into Contracts/Arrangements/Transactions with related parties as per section 188 (1) - Form AOC - 2-05042019
